Priority review for Welireg is based on data from the Phase II LITESPARK-015 trial, which showed promising response rates in ...

The government agency says X no longer suits its communication needs.

Approval was based on results from multiple studies, which demonstrated a slowing of cognitive decline in patients with ...

A surge in biotech startup out-licensing deals from the country are paving the way for increased IPO and M&A activities.

Campaign encourages the use of low-dose aspirin to help reduce the risk of preeclampsia and the complications that come with ...

Under terms of the deal, AbbVie will provide Neomorph with an upfront payment and the potential to earn up to $1.64 billion ...

Application is supported by results from the DEVOTE study, which suggested that two doses of Spinraza (nusinerse) 50 mg taken ...

CIII nasal spray, marking the first monotherapy to be approved for adults with treatment-resistant depression (TRD).

Trial findings show long-term recurrence-free survival in patients with low-grade upper tract urothelial cancer treated with ...

As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in ...

The cobas liat test aims to improve patient outcomes by offering rapid, accurate results in decentralized and community-based ...

Panel participants share an optimistic outlook for integrating new innovations, tacking community-level challenges, and more.